84314-03-4Relevant academic research and scientific papers
6-PHENYL-4,5-DIHYDROPYRIDAZIN-3(2H)-ONE DERIVATIVES AS PDE3A AND PDE3B INHIBITORS FOR TREATING CANCER
-
Page/Page column 175; 176, (2019/02/15)
The present invention provides 6-phenyl-4,5-dihydropyridazin-3(2H)- one derivatives of formula (I) : The present invention provides 6-phenyl-4,5-dihydropyridazin-3(2H)- one derivatives of formula (I) :
6-(4-Morpholino-phenyl)-4,5-dihydro-2H-pyridazine-3-ones: potent platelet aggregation inhibitors and antithrombotics
Goeschke, R,Gainer, J,Howarth, GA,Wallis, RB,Kerry, R,et al.
, p. 715 - 721 (2007/10/02)
A series of di- and tri-substituted 6-phenyl-4,5-dihydro-2H-pyridazine-3-ones is described.The compounds were designed to be antithrombotics and were assessed for their inhibitory properties on platelet aggregation and on thrombus formation in an arteriov
Method of treating thrombotic disease with pyridazinones
-
, (2008/06/13)
The invention concerns compounds of formula I STR1 wherein R is a fluorine, bromine or iodine atom or the amino, acetylamino, methyl, cyano, hydroxyl, methoxy or trifluoromethyl group, the tautomeric forms thereof, and acid addition salts of the compounds
